14
Views
30
CrossRef citations to date
0
Altmetric
Signal Transduction

Removal of C-Terminal Src Kinase from the Immune Synapse by a New Binding Protein

, , , , , , , & show all
Pages 2227-2241 | Received 02 Sep 2004, Accepted 10 Dec 2004, Published online: 27 Mar 2023

REFERENCES

  • Alonso, A., S. Rahmouni, S. Williams, M. van Stipdonk, L. Jaroszewski, A. Godzik, R. T. Abraham, S. P. Schoenberger, and T. Mustelin. 2003. Tyrosine phosphorylation of VHR by ZAP-70. Nat. Immunol. 4:44–48.
  • Amrein, K., and B. M. Sefton. 1988. Mutation of a site of tyrosine phosphorylation in the lymphocyte-specific tyrosine protein kinase, p56lck, reveals its oncogenic potential in fibroblasts. Proc. Natl. Acad. Sci. USA 85:4247–4251.
  • Barnes, C. J., F. Li, M. Mandal, Z. Yang, A. A. Sahin, and R. Kumar. 2002. Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors. Cancer Res. 62:1251–1255.
  • Bergman, M., T. Mustelin, C. Oetken, J. Partanen, N. A. Flint, K. E. Amrein, M. Autero, P. Burn, and K. Alitalo. 1992. The human p50csk tyrosine kinase phosphorylates Lck at Tyr-505 and downregulates its catalytic activity. EMBO J. 11:2919–2924.
  • Brdicka, T., D. Pavlistova, A. Leo, E. Bruyns, V. Korinek, P. Angelisova, J. Scherer, A. Shevchenko, I. Hilgert, J. Cerny, K. Drbal, Y. Kuramitsu, B. Kornacker, V. Horejsi, and B. Schraven. 2000. Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adapter protein, binds the protein tyrosine kinase csk and is involved in regulation of T-cell activation. J. Exp. Med. 191:1591–1604.
  • Cahir McFarland, E. D., T. R. Hurley, J. T. Pingel, B. M. Sefton, A. Shaw, and M. L. Thomas. 1993. Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc. Natl. Acad. Sci. USA 90:1402–1406.
  • Chan, A. C., M. Dalton, R. Johnson, G. H. Kong, T. Wang, R. Thoma, and T. Kurosaki. 1995. Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J. 14:2499–2508.
  • Chan, A. C., M. Iwashima, C. W. Turck, and A. Weiss. 1992. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR ζ chain. Cell 71:649–662.
  • Chow, L. M. L., M. Fournel, D. Davidson, and A. Veillette. 1993. Negative regulation of T-cell receptor signalling by the tyrosine kinase p50csk. Nature 365:156–160.
  • Cloutier, J. F., and A. Veillette. 1996. Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. EMBO J. 15:4909–4918.
  • Cloutier, J. F., and A. Veillette. 1999. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med. 189:111–121.
  • Couture, C., G. Baier, C. Oetken, S. Williams, D. Telford, A. Marie-Cardine, G. Baier-Bitterlich, S. Fischer, P. Burn, A. Altman, and T. Mustelin. 1994. Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation. Mol. Cell. Biol. 14:5249–5258.
  • Danielian, S., A. Alcover, L. Polissard, M. Stefanescu, O. Acuto, S. Fischer, and R. Fagard. 1992. Both T-cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck : CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck. Eur. J. Immunol. 22:2915–2921.
  • Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498.
  • Gallouzi, I. E., F. Parker, K. Chebli, F. Maurier, E. Labourier, I. Barlat, J. P. Capony, B. Tocque, and T. Tazi. 1998. A novel phosphorylation-dependent RNase activity of GAP-SH3 binding protein: a potential link between signal transduction and RNA stability. Mol. Cell. Biol. 18:3956–3965.
  • Gibson, S., A. August, D. Branch, B. Dupont, and G. M. Mills. 1996. Functional LCK Is required for optimal CD28-mediated activation of the TEC family tyrosine kinase EMT/ITK. J. Biol. Chem. 271:7079–7083.
  • Gjörloff-Wingren, A., M. Saxena, S. Williams, D. Hammi, and T. Mustelin. 1999. Characterization of TCR-induced receptor-proximal signaling events negatively regulated by the protein tyrosine phosphatase PEP. Eur. J. Immunol. 29:3845–3854.
  • Guitard, E., F. Parker, F., R. Millon, J. Abecassis, and B. Tocque. 2001. G3BP is overexpressed in human tumors and promotes S phase entry. Cancer Lett. 162:213–221.
  • Heyeck, S. D., H. M. Wilcox, S. C. Bunnell, and L. J. Berg. 1997. Lck phosphorylates the activation loop tyrosine of the Itk kinase domain and activates Itk kinase activity. J. Biol. Chem. 272:25401–25408.
  • Hogquist, K. A., M. A. Gavin, and M. J. Bevan. 1993. Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture. J. Exp. Med. 177:1469–1473.
  • Hsi, E. D., J. N. Siegel, Y. Minami, E. T. Luong, R. D. Klausner, and L. E. Samelson. 1989. T-cell activation induces rapid tyrosine phosphorylation of a limited number of cellular substrates. J. Biol. Chem. 264:10836–10842.
  • Iivanainen, A. V., C. Lindqvist, T. Mustelin, and L. C. Andersson. 1990. Phosphotyrosine phosphatases are involved in reversion of T lymphoblastic proliferation. Eur. J. Immunol. 20:2509–2512.
  • Iwashima, M., B. A. Irving, N. S. C. van Oers, A. C. Chan, and A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science 263:1136–1139.
  • Jascur, T., J. Gilman, and T. Mustelin. 1997. Involvement of phosphatidylinositol 3-kinase in NFAT activation in T cells. J. Biol. Chem. 272:14483–14488.
  • June, C. H., M. C. Fletcher, J. A. Ledbetter, and L. E. Samelson. 1990. Increases in tyrosine phosphorylation are detected before phospholipase C activation after T-cell receptor stimulation. J. Immunol. 144:1591–1598.
  • June, C. H., M. C. Fletcher, J. A. Ledbetter, G. L. Schieven, J. N. Siegel, A. F. Phillips, and L. E. Samelson. 1990. Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc. Natl. Acad. Sci. USA 87:7722–7727.
  • Kawabuchi, M., Y. Satomi, T. Takao, Y. Shimonishi, S. Nada, K. Nagai, A. Tarakhovsky, and M. Okada. 2000. Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature 404:999–1003.
  • Koretzky, G. A., J. Picus, M. L. Thomas, and A. Weiss, A. 1990. Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway. Nature 346:66–68.
  • Liu, K. Q., S. C. Bunnell, C. B. Gurniak, and L. J. Berg. 1998. T-cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J. Exp. Med. 187:1721–1727.
  • Marth, J. D., J. A. Cooper, C. S. King, S. F. Ziegler, D. A. Tinker, R. W. Overell, E. G. Krebs, and R. Perlmutter. 1988. Neoplastic transformation induced by an activated lymphocyte-specific protein tyrosine kinase (pp56lck) Mol. Cell. Biol. 8:540–550.
  • Molina, T. J., K. Kishihara, D. P. Siderowski, W. van Ewijk, A. Narendran, E. Timms, A. Wakeham, C. J. Paige, K.-U. Hartman, A. Veillette, D. Davidson, and T. W. Mak. 1992. Profound block in thymocyte development in mice lacking p56lck. Nature 357:161–164.
  • Mustelin, T. 1994. Src family tyrosine kinases in leukocytes. R. G. Landes Co., Austin, Tex.
  • Mustelin, T., R. T. Abraham, C. E. Rudd, A. Alonso, and J. J. Merlo. 2002. Protein tyrosine phosphorylation in T-cell signaling. Front. Biosci. 7:918–969.
  • Mustelin, T., and A. Altman. 1990. Dephosphorylation and activation of the T-cell tyrosine kinase pp56lck by the leukocyte common antigen (CD45) Oncogene 5:809–813.
  • Mustelin, T., and P. Burn. 1993. Regulation of src-family tyrosine kinases in lymphocytes. Trends Biochem. Sci. 18:215–220.
  • Mustelin, T., K. M. Coggeshall, and A. Altman. 1989. Rapid activation of the T-cell tyrosine protein kinase pp56lck by the CD45 phosphotyrosine phosphatase. Proc. Natl. Acad. Sci. USA 86:6302–6306.
  • Mustelin, T., K. M. Coggeshall, N. Isakov, and A. Altman. 1990. Tyrosine phosphorylation is required for T-cell antigen receptor-mediated activation of phospholipase C. Science 247:1584–1587.
  • Mustelin, T., G.-S. Feng, N. Bottini, A. Alonso, N. Kholod, D. Birle, J. J. Merlo, and H. Huynh. 2002. Protein tyrosine phosphatases. Front. Biosci. 7:85–142.
  • Nada, S., M. Okada, A. MacAuley, J. A. Cooper, and H. Nakagawa. 1991. Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c - src. Nature 351:69–72.
  • Nada, S., T. Yagi, H. Takeda, T. Tokunaga, H. Nakagawa, Y. Ikawa, M. Okada, and S. Aizawa. 1993. Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73:1125–1135.
  • Neumeister, E. N., Y. Zhu, S. Richard, C. Terhorst, A. C. Chan, and A. S. Shaw. 1995. Binding of ZAP-70 to phosphorylated T-cell receptor zeta and eta enhances its autophosphorylation and generates specific binding sites for SH2 domain-containing proteins. Mol. Cell. Biol. 15:3171–3178.
  • Oetken, C., C. Couture, M. Bergman, N. Bonnefoy-Bérard, S. Williams, K. Alitalo, K., P. Burn, and T. Mustelin, T. 1994. TCR/CD3-triggering causes activation of the p50csk tyrosine kinase and engagement of its SH2 domain. Oncogene 9:1625–1631.
  • Oetken, C., M. von Willebrand, A. Marie-Cardine, T. Pessa-Morikawa, A. Stähls, S. Fischer, and T. Mustelin. 1994. Induction of hyperphosphorylation and activation of the p56lck protein tyrosine kinase by phenylarsine oxide, a phosphotyrosine phosphatase inhibitor. Mol. Immunol. 31:1295–1302.
  • O'Shea, J. J., D. W. McVivar, T. L. Bailey, C. Burns, and M. J. Smyth. 1992. Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc. Natl. Acad. Sci. USA 89:10306–10310.
  • Ostergaard, H. L., D. A. Shackelford, T. R. Hurley, P. Johnson, R. Hyman, B. M. Sefton, and I. S. Trowbridge. 1989. Expression of CD45 alters phosphorylation of the Lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines. Proc. Natl. Acad. Sci. USA 86:8959–8963.
  • Parker, F., F. Maurier, I. Delumeau, M. Duchesne, D. Faucher, L. Debussche, A. Dugue, F. Schweighoffer, and B. Tocque. 1996. A Ras-GTPase-activating protein SH3-domain-binding protein. Mol. Cell. Biol. 16:2561–2569.
  • Partanen, J., E. Armstrong, M. Bergman, T. P. Mäkelä, H. Hirvonen, K. Huebner, and K. Alitalo. 1991. Cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src). Oncogene 6:2013–2018.
  • Perez-Villar, J. J., and S. B. Kanner. 1999. Regulated association between the tyrosine kinase Emt/Itk/Tsk and phospholipase-C γ1 in human T lymphocytes. J. Immunol. 163:6435–6441.
  • Pingel, J. T., and M. L. Thomas. 1989. Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation. Cell 58:1055–1065.
  • Sanders, M. E., M. W. Makgoba, and S. Shaw. 1988. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets. Immunol. Today 9:195–199.
  • Saxena, M., S. Williams, K. Taskén, and T. Mustelin. 1999. Crosstalk between cAMP-dependent kinase and MAP kinase through hematopoietic protein tyrosine phosphatase (HePTP). Nat. Cell Biol. 1:305–311.
  • Secrist, J. P., L. A. Burns, L. Karnitz, G. A. Koretzky, and R. T. Abraham. 1993. Stimulatory effects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events. J. Biol. Chem. 268:5886–5893.
  • Sefton, B. M. 1990. The Lck tyrosine protein kinase. Oncogene 6:683–686.
  • Soncini, C., I. Berdo, and G. Draetta. 2001. Ras-GAP SH3 binding protein (G3BP) is a modulator of USP10, a novel human ubiquitin specific ligase. Oncogene 20:3869–3879.
  • Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the Lck tyrosine kinase in signal transduction through the T-cell antigen receptor. Cell 70:585–593.
  • Torgersen, K. M., T. Vang, H. Abrahamsen, S. Yaqub, V. Horejsi, B. Schraven, B. Rolstad, T. Mustelin, and K. Taskén. 2001. Release from tonic inhibition of T-cell activation through transient displacement of C-terminal Src kinase (Csk) from lipid rafts. J. Biol. Chem. 276:29313–29318.
  • Tsygankov, A. Y., B. M. Bröker, J. Fargnoli, J. A. Ledbetter, and J. B. Bolen. 1992. Activation of tyrosine kinase p60fyn following T-cell antigen receptor cross-linking. J. Biol. Chem. 267:18259–18262.
  • Vang, T., K. M. Torgersen, V. Sundvold, S. Saxena, F. O. Levy, B. S. Skälhegg, V. Hansson, T. Mustelin, and K. Taskén. 2001. Activation of the COOH-terminal Src kinase (Csk) by cAMP-dependent protein kinase inhibits signaling through the T-cell receptor. J. Exp. Med. 193:497–507.
  • van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2:423–429.
  • von Willebrand, M., T. Jascur, N. Bonnefoy-Bérard, H. Yano, A. Altman, Y. Matsuda, and T. Mustelin. 1996. Inhibition of phosphatidylinositol 3-kinase blocks TCR/CD3-induced activation of the mitogen-activated kinase Erk2. Eur. J. Biochem. 235:828–835.
  • von Willebrand, M., S. Williams, M. Saxena, J. Gilman, P. Tailor, T. Jascur, G. P. Amarante-Mendes, D. R. Green, and T. Mustelin. 1998. Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688. J. Biol. Chem. 273:3994–4000.
  • Virolle, T., E. D. Adamson, V. Baron, D. Birle, D. Mercola, T. Mustelin, and I. de Belle. 2001. PTEN is directly transactivated in vivo by Egr-1 during irradiation-induced signalling. Nat. Cell Biol. 3:1124–1128.
  • Wang, X., A. Gjörloff-Wingren, M. Saxena, N. Pathan, J. C. Reed, and T. Mustelin. 2000. The tumor suppressor PTEN regulates T-cell survival and antigen receptor signaling by acting as a phosphatidylinositol 3-phosphatase. J. Immunol. 164:1934–1939.
  • Wang, X., H. Huynh, H., A. Gjörloff-Wingren, E. Monosov, M. Stridsberg, M. Fukuda, and T. Mustelin. 2002. Enlargement of secretory vesicles by protein tyrosine phosphatase PTP-MEG2 in RBL mast cells and Jurkat T cells. J. Immunol. 168:4612–4619.
  • Williams, S., C. Couture, J. Gilman, T. Jascur, M. Deckert, A. Altman, and T. Mustelin. 1997. Reconstitution of TCR-induced Erk2 kinase activation in Lck-negative JCaM1 cells by Syk, but not Zap. Eur. J. Biochem. 245:84–90.
  • Zhang, W. J., J. Sloan-Lancaster, J. Kitchen, R. P. Trible, and L. E. Samelson. 1998. LAT: the ZAP-70 tyrosine kinase substrate that links T-cell receptor to cellular activation. Cell 92:83–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.